EUVIMEDEUVIMED entdecken
Crossref

Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos

Diana Isabel Rocha, Flores Ribeiro, Rui, Novo, Ana

Medicina Interna · 08.03.2023

DOI: 10.24950/rspmi.1718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Interna, erschienen am 08.03.2023. Verfasst von Diana Isabel Rocha und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statin-induced necrotizing myopathy is an immune-mediated adverse effect that, although rare, should be suspected in the presence of myalgia and rhabdomyolysis, which can persist even after discontinuation of the drug. The prognosis is generally favourable, requiring immunosuppressive therapy in most cases. We present two clinical cases with histological documentation, the second with greater severity requiring therapy with intravenous immunoglobulins. Statins are often prescribed for their role in reducing cardiovascular risk, so clinicians need to be aware of this entity so that treatment can be quickly started, preventing sequelae.

Schlagwörter

statin adverse effectsrhabdomyolysismyalgiaimmunosuppressive therapyintravenous immunoglobulindrug-induced myopathyhistopathology

Zitieren

APA

Rocha, D. I., Ribeiro, F., Rui, Novo, & Ana (2023). Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos. Medicina Interna. https://doi.org/10.24950/rspmi.1718

Vancouver

Rocha DI, Ribeiro F, Rui, Novo, Ana. Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos. Medicina Interna. 2023. doi:10.24950/rspmi.1718

BibTeX
@article{Rocha2023,
  author = {Rocha, Diana Isabel and Ribeiro, Flores and Rui and Novo and Ana},
  title = {Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos},
  journal = {Medicina Interna},
  year = {2023},
  doi = {10.24950/rspmi.1718}
}
Kostenlos starten →